Your browser doesn't support javascript.
loading
COVID-19 Vaccination Rates Among North Dakota Residents Who Gave Birth Between April 1, 2021, and July 15, 2022.
Aguilar, Olenka; Woinarowicz, Mary.
Afiliação
  • Aguilar O; Olenka Aguilar is with the CDC Foundation, Atlanta, GA. Mary Woinarowicz is with the North Dakota Department of Health and Human Services, Bismarck.
  • Woinarowicz M; Olenka Aguilar is with the CDC Foundation, Atlanta, GA. Mary Woinarowicz is with the North Dakota Department of Health and Human Services, Bismarck.
Am J Public Health ; 114(2): 237-240, 2024 02.
Article em En | MEDLINE | ID: mdl-38175966
ABSTRACT
Objectives. To assess COVID-19 vaccination rates among North Dakota residents who gave birth. Methods. We used data from North Dakota Vital Records and the North Dakota Immunization Information System for North Dakota residents who gave birth between April 1, 2021, and July 15, 2022. We evaluated vaccination with 1 dose, primary series, and monovalent booster for timing before and during pregnancy and postpartum. Results. Among North Dakota residents who gave birth, 44% received at least 1 COVID-19 vaccine, 34% received a complete primary series, and 10% received a monovalent booster dose. Among those who received a COVID-19 vaccine, the majority was vaccinated during pregnancy. Obstetrics and gynecology providers administered just 9.2% of COVID-19 vaccine doses. Conclusions. Most persons who gave birth in North Dakota did not receive the primary series of the COVID-19 vaccine while pregnant. Providers have an opportunity to counsel their pregnant and recently pregnant patients on vaccine recommendations. (Am J Public Health. 2024;114(2)237-240. https//doi.org/10.2105/AJPH.2023.307500).
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Am J Public Health Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Am J Public Health Ano de publicação: 2024 Tipo de documento: Article